Resources

Reliable mental health information should help you feel more informed, not more overwhelmed.

At Claritiv Health, we have selected clear, trustworthy resources from national health agencies, the FDA, and peer-reviewed medical research. These materials can help you better understand common mental health conditions, treatment options, and when to seek support.

Clear Information from Trusted Sources

Depression

Depression can affect mood, energy, concentration, sleep, relationships, and daily life. The National Institute of Mental Health explains common symptoms, treatment options, and ways to find help.

Anxiety Disorders

Anxiety disorders involve more than occasional stress or worry. Symptoms may continue over time and interfere with work, relationships, or everyday activities.

Post-Traumatic Stress Disorder

PTSD can develop after a traumatic experience and may affect sleep, concentration, relationships, emotional well-being, and a person’s sense of safety.

Obsessive-Compulsive Disorder

OCD may involve recurring unwanted thoughts, repetitive behaviors, or both. These symptoms can cause distress and interfere with daily responsibilities.

Bipolar Disorder

Bipolar disorder can involve significant changes in mood, energy, activity, and concentration. It is more complex than ordinary emotional ups and downs and requires an individual clinical evaluation.

Talk Therapy

Psychotherapy, also known as Talk Therapy, may use structured approaches to help people understand thoughts, emotions, behaviors, and difficult experiences. The approach used depends on the person’s needs and goals.

IV Ketamine and Depression Research

Researchers have studied ketamine as a possible option for some people with depression, including treatment-resistant depression. Ketamine is FDA-approved as an anesthetic. Its use for mental health conditions is off-label.

This peer-reviewed review discusses clinical research involving ketamine and depression. Some sections are written for medical and scientific readers.

SPRAVATO® / Esketamine

SPRAVATO® is an FDA-approved esketamine nasal spray for treatment-resistant depression in adults. It is distinct from ketamine.

Patients self-administer SPRAVATO® under clinical supervision in a certified healthcare setting. The FDA prescribing information explains approved uses, monitoring requirements, safety warnings, and treatment restrictions.

Explore Claritiv Health Resources

Find practical information about our services, payment, privacy, and getting started on our FAQ page. Visit the Blog for more articles about mental health conditions and treatment topics.

Crisis and Emergency Resources

Claritiv Health provides outpatient mental health care. We do not replace emergency or crisis services.

If you or someone else is in immediate danger, call 911 or go to the nearest emergency department.

For confidential crisis support in the United States, call or text 988 to reach the 988 Suicide & Crisis Lifeline.

Visit the 988 Suicide & Crisis Lifeline

Medical Disclaimer

The information on this page is for general educational purposes only and is not a substitute for medical advice, diagnosis, or treatment. External resources are provided for education and do not determine which care may be appropriate for you. The care that may be appropriate for you can only be determined through an individual clinical evaluation.

Visit Claritiv Health